2002
DOI: 10.1111/j.1349-7006.2002.tb01341.x
|View full text |Cite
|
Sign up to set email alerts
|

β‐Hydroxyisovalerylshikonin Is a Novel and Potent Inhibitor of Protein Tyrosine Kinases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
27
0

Year Published

2003
2003
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 37 publications
(29 citation statements)
references
References 28 publications
2
27
0
Order By: Relevance
“…It has been reported that ␤-HIVS inhibits the activity of several tyrosine kinases, such as v-Src and a receptor for EGF in vitro (13), and that it exerts its apoptosis-inducing activity via the inhibition of tyrosine kinases (14). Thus, it is possible that tyrosine kinases might be direct targets of ␤-HIVS in the induction of apoptosis.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…It has been reported that ␤-HIVS inhibits the activity of several tyrosine kinases, such as v-Src and a receptor for EGF in vitro (13), and that it exerts its apoptosis-inducing activity via the inhibition of tyrosine kinases (14). Thus, it is possible that tyrosine kinases might be direct targets of ␤-HIVS in the induction of apoptosis.…”
Section: Discussionmentioning
confidence: 99%
“…Most of the PTK inhibitors reported to date, including STI571, ZD1839, SU5416, and PD173074, have chemical structures that resemble the structure of ATP and compete with ATP for binding to the ATP binding site in the catalytic domain of the PTKs, with resultant inhibition of enzymatic activities. By contrast to these ATP-competitive inhibitors of PTK, the shikonin derivative ␤-hydroxyisovalerylshikonin (␤-HIVS), isolated from the plant Lithospermum radix, inhibits the activity of v-Src in an ATP-non-competitive manner (13). This feature of ␤-HIVS is very useful for the inhibition of PTK activity in vivo because ␤-HIVS does not need to compete with ATP in the intracellular environment.…”
Section: From the Laboratory Of Biological Chemistry School Of Pharmmentioning
confidence: 99%
See 2 more Smart Citations
“…These results suggest that b-HIVS might inhibit Bcr-Abl or other tyrosine protein kinases. Indeed, b-HIVS inhibits the activity of several tyrosine kinases, such as v-Src and a receptor for EGF in vitro (Hashimoto et al, 2002). Thus, it is likely that tyrosine kinases are possible targets of b-HIVS.…”
Section: Discussionmentioning
confidence: 99%